BASF at the 2nd window: weak signal, discipline required
BASF is at week 8 of a BUY with signal strength at 44 out of 100 and a negative confirmation week. The model calls for caution: we've reached the 2nd position-reduction window.
Barclays at the first window: active signal, tension to manage
Barclays plc is at week 6 of an active long. The first statistical take-profit window is now. The buy signal is fading, with strength at 66 out of 100 and a double bottom in the 409 area as reference support.
BAE Systems at week 3 of sell signal: low strength, opening not recommended
BAE Systems is at week 3 of a sell signal with strength at 23 out of 100 and fading. Our model flags trading not recommended: high-risk conditions for new short entries.
AstraZeneca: sell signal unconfirmed, caution before acting
Three observation weeks in and AstraZeneca's sell signal remains unconfirmed by the market. Signal strength has dropped to 2 out of 100, the quality band flags trading as not recommended: the picture calls for patience, not action.
Allianz SE: second-week sell signal, minimal strength and trading not recommended
Sell signal on Allianz SE in its second week, but signal strength is at model minimum: 2 out of 100. The stock ranks 43rd among 57 EU-UK sell signals. Trading not recommended per our model.
Adidas: signal still alive but strength fades — cautious management ahead of week-6 window
Adidas is in week 5 of a buy with signal strength at 40 out of 100 and a negative confirmation week. The signal holds but fades: the discipline points to preparing for the week-6 management window.